Dianthus Therapeutics
DNTH
DNTH
63 hedge funds and large institutions have $406M invested in Dianthus Therapeutics in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
+9
Holders Change %
+16.67%
% of All Funds
1.37%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
16
Increased
23
Reduced
7
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$30.1M |
| 2 |
BlackRock
New York
|
+$9.54M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$6.79M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.02M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.52M |
